amoxapine has been researched along with Psychotic Disorders in 6 studies
Amoxapine: The N-demethylated derivative of the antipsychotic agent LOXAPINE that works by blocking the reuptake of norepinephrine, serotonin, or both; it also blocks dopamine receptors. Amoxapine is used for the treatment of depression.
amoxapine : A dibenzooxazepine compound having a chloro substituent at the 2-position and a piperazin-1-yl group at the 11-position.
Psychotic Disorders: Disorders in which there is a loss of ego boundaries or a gross impairment in reality testing with delusions or prominent hallucinations. (From DSM-IV, 1994)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Loxapine is a neuroleptic of the dibenzoxazepine class; it is metabolized in vivo to desmethylloxapine (amoxapine) and 8-hydroxyamoxapine, two compounds with antidepressant activity." | 5.27 | Loxapine in the treatment of psychotic-depressive disorders: Measurement of antidepressant metabolites. ( Burch, EA; Goldschmidt, TJ, 1983) |
| "Amoxapine was associated with less EPS and less prolactin elevation than risperidone." | 2.71 | Amoxapine as an atypical antipsychotic: a comparative study vs risperidone. ( Apiquian, R; de la Fuente-Sandoval, C; Fresan, A; Herrera-Estrella, M; Kapur, S; Nicolini, H; Ulloa, RE; Vazquez, A, 2005) |
| "Loxapine is a neuroleptic of the dibenzoxazepine class; it is metabolized in vivo to desmethylloxapine (amoxapine) and 8-hydroxyamoxapine, two compounds with antidepressant activity." | 1.27 | Loxapine in the treatment of psychotic-depressive disorders: Measurement of antidepressant metabolites. ( Burch, EA; Goldschmidt, TJ, 1983) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (50.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Apiquian, R | 1 |
| Fresan, A | 1 |
| Ulloa, RE | 1 |
| de la Fuente-Sandoval, C | 1 |
| Herrera-Estrella, M | 1 |
| Vazquez, A | 1 |
| Nicolini, H | 1 |
| Kapur, S | 2 |
| Luna, OC | 1 |
| Jayatilaka, A | 1 |
| Walker, V | 1 |
| McKnight, MA | 1 |
| Ross, DR | 1 |
| Lipper, S | 1 |
| Burch, EA | 1 |
| Goldschmidt, TJ | 1 |
| Cho, R | 1 |
| Jones, C | 1 |
| McKay, G | 1 |
| Zipursky, RB | 1 |
| Gupta, S | 1 |
| Racaniello, AA | 1 |
1 trial available for amoxapine and Psychotic Disorders
| Article | Year |
|---|---|
Amoxapine as an atypical antipsychotic: a comparative study vs risperidone.
Topics: Adolescent; Adult; Amoxapine; Antipsychotic Agents; Dose-Response Relationship, Drug; Double-Blind M | 2005 |
5 other studies available for amoxapine and Psychotic Disorders
| Article | Year |
|---|---|
Amoxapine and extrapyramidal symptoms.
Topics: Adult; Amoxapine; Basal Ganglia Diseases; Dibenzoxazepines; Humans; Male; Psychotic Disorders | 1984 |
Amoxapine and extrapyramidal symptoms.
Topics: Amoxapine; Basal Ganglia Diseases; Dibenzoxazepines; Female; Humans; Male; Middle Aged; Psychotic Di | 1984 |
Loxapine in the treatment of psychotic-depressive disorders: Measurement of antidepressant metabolites.
Topics: Adult; Amoxapine; Depressive Disorder; Dibenzoxazepines; Drug Therapy, Combination; Female; Humans; | 1983 |
Is amoxapine an atypical antipsychotic? Positron-emission tomography investigation of its dopamine2 and serotonin2 occupancy.
Topics: Adult; Amoxapine; Brain; Female; Humans; Male; Psychotic Disorders; Receptors, Dopamine D2; Receptor | 1999 |
Neuroleptic malignant syndrome associated with amoxapine and lithium in an older adult.
Topics: Amoxapine; Antidepressive Agents, Second-Generation; Antimanic Agents; Depressive Disorder; Humans; | 2000 |